Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy
Conditions: Metastatic Breast Cancer; Locally Advanced Breast Cancer Intervention: Drug: Palbociclib Sponsor: Consorzio Oncotech Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Research | Women